These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 18261977)
1. Efficient long-term and high-yielded production of a recombinant proteoglycan in eukaryotic HEK293 cells using a membrane-based bioreactor. Adam E; Sarrazin S; Landolfi C; Motte V; Lortat-Jacob H; Lassalle P; Delehedde M Biochem Biophys Res Commun; 2008 May; 369(2):297-302. PubMed ID: 18261977 [TBL] [Abstract][Full Text] [Related]
2. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium. Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647 [TBL] [Abstract][Full Text] [Related]
3. Production of human alpha-1-antitrypsin from transgenic rice cell culture in a membrane bioreactor. McDonald KA; Hong LM; Trombly DM; Xie Q; Jackman AP Biotechnol Prog; 2005; 21(3):728-34. PubMed ID: 15932249 [TBL] [Abstract][Full Text] [Related]
4. Improving performance of mammalian cells in fed-batch processes through "bioreactor evolution". Prentice HL; Ehrenfels BN; Sisk WP Biotechnol Prog; 2007; 23(2):458-64. PubMed ID: 17311405 [TBL] [Abstract][Full Text] [Related]
5. Anti-apoptotic genes Aven and E1B-19K enhance performance of BHK cells engineered to express recombinant factor VIII in batch and low perfusion cell culture. Nivitchanyong T; Martinez A; Ishaque A; Murphy JE; Konstantinov K; Betenbaugh MJ; Thrift J Biotechnol Bioeng; 2007 Nov; 98(4):825-41. PubMed ID: 17514750 [TBL] [Abstract][Full Text] [Related]
6. The enhancement of recombinant protein production by polymer nanospheres in cell suspension culture. Ryu JH; Kim MS; Lee GM; Choi CY; Kim BS Biomaterials; 2005 May; 26(14):2173-81. PubMed ID: 15576193 [TBL] [Abstract][Full Text] [Related]
7. Optimal conditions for freezing CHO-S and HEK293-EBNA cell lines: influence of Me2SO, freeze density, and PEI-mediated transfection on revitalization and growth of cells, and expression of recombinant protein. Kleman MI; Oellers K; Lullau E Biotechnol Bioeng; 2008 Aug; 100(5):911-22. PubMed ID: 18351658 [TBL] [Abstract][Full Text] [Related]
8. Production of a secreted glycoprotein from an inducible promoter system in a perfusion bioreactor. Lipscomb ML; Mowry MC; Kompala DS Biotechnol Prog; 2004; 20(5):1402-7. PubMed ID: 15458323 [TBL] [Abstract][Full Text] [Related]
9. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system. Tang YJ; Ohashi R; Hamel JF Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696 [TBL] [Abstract][Full Text] [Related]
10. Manufacturing of recombinant therapeutic proteins in microbial systems. Graumann K; Premstaller A Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246 [TBL] [Abstract][Full Text] [Related]
11. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells. Côté J; Garnier A; Massie B; Kamen A Biotechnol Bioeng; 1998 Sep; 59(5):567-75. PubMed ID: 10099373 [TBL] [Abstract][Full Text] [Related]
12. Bioreactor strategies for improving production yield and functionality of a recombinant human protein in transgenic tobacco cell cultures. Huang TK; Plesha MA; Falk BW; Dandekar AM; McDonald KA Biotechnol Bioeng; 2009 Feb; 102(2):508-20. PubMed ID: 18767186 [TBL] [Abstract][Full Text] [Related]
13. Comparison of fluidized bed and ultrasonic cell-retention systems for high cell density mammalian cell culture. Dürrschmid MP; Landauer K; Simic G; Klug H; Keijzer T; Trampler F; Oudshoorn A; Gröschl M; Müller D; Doblhoff-Dier O Biotechnol Prog; 2003; 19(3):1045-8. PubMed ID: 12790677 [TBL] [Abstract][Full Text] [Related]
15. Semicontinuous bioreactor production of a recombinant human therapeutic protein using a chemically inducible viral amplicon expression system in transgenic plant cell suspension cultures. Huang TK; Plesha MA; McDonald KA Biotechnol Bioeng; 2010 Jun; 106(3):408-21. PubMed ID: 20198659 [TBL] [Abstract][Full Text] [Related]
16. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots. Sivakumar G Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730 [TBL] [Abstract][Full Text] [Related]
17. Application of a cell-once-through perfusion strategy for production of recombinant antibody from rCHO cells in a Centritech Lab II centrifuge system. Kim BJ; Chang HN; Oh DJ Biotechnol Prog; 2007; 23(5):1186-97. PubMed ID: 17691812 [TBL] [Abstract][Full Text] [Related]
18. Insect cell culture for industrial production of recombinant proteins. Ikonomou L; Schneider YJ; Agathos SN Appl Microbiol Biotechnol; 2003 Jul; 62(1):1-20. PubMed ID: 12733003 [TBL] [Abstract][Full Text] [Related]
19. An actively mixed mini-bioreactor for protein production from suspended animal cells. Diao J; Young L; Zhou P; Shuler ML Biotechnol Bioeng; 2008 May; 100(1):72-81. PubMed ID: 18078290 [TBL] [Abstract][Full Text] [Related]
20. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor. Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]